Latest AI and machine learning research in dyslipidemia for healthcare professionals.
Large-artery atherosclerosis stroke (LAA) is the main subtype of ischemic stroke. Currently, the diagnosis of LAA is confirmed through magnetic resonance imaging. At present, numerous substances are extensively studied as biomarkers, including metabolites, inflammatory factors, RNA, and more. In this study, we incorporated LAA peripheral blood data from various datasets and employed methods such a...
Type 2 diabetes mellitus (T2DM) is a major risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), and their convergence presents a significant therapeutic challenge. Palmatine, an isoquinoline alkaloid with lipid-regulating and anti-inflammatory properties, is a promising candidate; however, its multi-target mechanisms remain undefined. To address this, we employed a seq...
Peripheral artery disease (PAD) affects more than 230 million people worldwide, with a disproportionate burden in low- and middle-income countries. PA...
Artificial intelligence (AI) can transform osteoporosis (OP) screening, but its application in high-risk, complex populations like postmenopausal wome...
AIMS: Biological age is increasingly recognized as a superior predictor of morbidity, mortality, compared with chronological age. Artificial intellige...
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has been shown to be intimately linked to the presence of insulin resista...
PURPOSE: This study aims to screen and identify potential atherosclerosis (AS) biomarkers associated with common plasticizer exposure, providing a bas...
BACKGROUND: Chronic kidney disease (CKD) and heart failure (HF) share pathophysiological mechanisms, rendering HF one of the most burdensome cardiovas...
OBJECTIVE: This work aims to enable adaptive Consumer Sleep Technologies (CSTs) for sleep intervention by developing a deep learning model for sleep s...
Cardiovascular events, predominantly ischemic, account for approximately 32% of global mortality and are expected to increase approximately 30% by 203...
Alzheimer's disease, a progressive neurodegenerative disorder, presents a growing global health challenge due to its increasing prevalence and lack of...
BACKGROUND: Asymptomatic left ventricular systolic dysfunction (LVSD) is a well-established precursor of overt heart failure (HF), yet it often remain...
CONTEXT: Adiposomes carry bioactive lipids that shape systemic metabolism and vascular function. OBJECTIVE: Building on our previous findings that obe...
BACKGROUND: Macrophage activation syndrome (MAS) secondary to Still's disease is a potentially fatal complication, associated with mortality rates exc...
OBJECTIVES: This study examined patterns of clustering of intermediate risk factors for Cardiovascular diseases (CVDs) in a rural South African popula...
BACKGROUND: Cardiovascular disease (CVD) is the most prevalent complication of Type 2 Diabetes Mellitus (T2DM) and a leading cause of mortality in thi...
Cardiovascular disease remains the predominant cause of global morbidity and mortality, with recent epidemiological trends indicating a resurgence in ...
BACKGROUND: Individuals with cardiovascular-kidney-metabolic (CKM) syndrome exhibit a substantially elevated risk of all-cause and cardiovascular-spec...